Chronic Traumatic Encephalopathy
The latest sourced reporting on Chronic Traumatic Encephalopathy from Dementias Today: dated, and plain about what the evidence does and does not show.
A test-tube and worm study reports that tau fibrils behave like catalysts for amyloid-beta, and that the shape of the tau fold decides how strong the effect is. It is bench work, not people.
An unselected community brain collection, nearly 15,000 slides stained for tau, and seven cases. This is the counterweight to the athlete series, and it comes with hard limits of its own.
An international panel convened at the 2025 Leon Thal Summit has published its priorities for chronic traumatic encephalopathy biomarkers, while restating that the disease can still only be confirmed after death.
A preliminary conference abstract from Toronto reports first-in-human scans with [18F]OXD-2314 in three retired collision-sport athletes and seven healthy controls, alongside tritiated ligand binding in post-mortem CTE tissue. Ten people were scanned in total.
A blinded autopsy comparison across six brain banks found the 2021 NINDS criteria for traumatic encephalopathy syndrome performed well at age 50 and over and poorly below it. The full analysis is a preprint, not yet peer reviewed.
An unsupervised analysis of tau density in 26 brain regions from 207 donors with chronic traumatic encephalopathy reports three orderly progression variants, a structure the authors say the current single staging scheme does not capture.